Cite
HARVARD Citation
van der Leest, P. et al. (2021). Circulating tumor DNA as a biomarker for monitoring early treatment responses of patients with advanced lung adenocarcinoma receiving immune checkpoint inhibitors. Molecular oncology. 15 (11), pp. 2910-2922. [Online].